ÀÎÁ¦´ëÇб³ ¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ¿ÍÀÇ ¸¸³²À» Áø½ÉÀ¸·Î ȯ¿µÇÕ´Ï´Ù.
¿¬±¸ÀÚÀÇ ÀÚ¼¼ÇÑ Á¤º¸¸¦ º¸½Ã·Á¸é »çÁøÀ» Ŭ¸¯ÇÏ½Ã¸é º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
ºÐ·ù |
±³¼ö |
¼º¸í |
±èÀ¯Ã¶ |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Yu-Chul Kim / |
¼Ò¼Ó |
Á¦¾à°øÇаú |
Á÷À§ |
ºÎ±³¼ö |
ÁÖ¿ä Çз |
¼¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇлç (2000.2)
¼¿ï´ëÇб³ ´ëÇпø ¾àÇм®»ç (2002.2) ¼¿ï´ëÇб³ ´ëÇпø ¾àÇйڻç (2005.2) |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. ¾à¹°ÀÇ Èí¼ö, ºÐÆ÷, ´ë»ç ¹× ¹è¼³ (ADME) ¿¬±¸
2. PK/PD Modeling and Simulation ¿¬±¸ 3. PBPK (Physiologically Based Pharmacokinetics) modeling ¿¬±¸ |
ºÐ·ù |
±³¼ö |
¼º¸í |
ÀÌ»ç¿ø |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Sa-Won Lee / |
¼Ò¼Ó |
Á¦¾à°øÇаú |
Á÷À§ |
ºÎ±³¼ö |
ÁÖ¿ä Çз |
Áß¾Ó´ë ¾à´ë Çлç (¾à»ç¸éÇã: 42281)
¼¿ï´ë ´ëÇпø ¹°¸®¾àÇÐ ¼®»ç (1996.2) ¼¿ï´ë ´ëÇпø ¹°¸®¾àÇÐ ¹Ú»ç (2001.2) |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. ½Å¾à Preformulation¹× ½ÅÁ¦Çü °³·®½Å¾à Á¦Á¦¼³°è
2. ³¿ë¼º¾à¹°ÀÇ °¡¿ëÈ ¹× ü³»Èí¼ö ÁõÁø ¿¬±¸ 3. Ãʹ̼¼ÀÔÀÚ¼º ¾à¹°Àü´Þü ¿¬±¸ 4. ÀÛ¿ëºÎÀ§ Ç¥Àû³ª³ëÀü´Þü ¿¬±¸ 5. »ýºÐÇØ¼º/»ýüÀûÇÕ¼º °íºÐÀÚ ¾à¹° Àü´Þü °³¹ß 6. ¿Âµµ°¨ÀÀ¼º¾à¹° Àü´Þü¿¬±¸- ÇÏÀ̵å·ÎÁ© ¿¬±¸ 7. Áö¼Ó¹æÃâ Á¦Çü ¿¬±¸- ¼¹æÇü¸¶ÀÌÅ©·ÎÀÔÀÚ, ¼¹æÇü¾×»óDepot¿¬±¸ 8. DDS °³·®½Å¾à ´ë·®»ý»ê°øÁ¤¿¬±¸ (CMC) |
ºÐ·ù |
±³¼ö |
¼º¸í |
±èÁ¤¾Ö |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Jung-Ae Kim / |
¼Ò¼Ó |
Á¦¾à°øÇаú |
Á÷À§ |
ºÎ±³¼ö |
ÁÖ¿ä Çз |
¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ ¾àÇлç
¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ ¾àÇм®»ç (¾àÁ¦ÇÐ) ¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ ¾àÇйڻç (»çȸ¾àÇÐ) |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. Outcomes research using healthcare big data (national claims, hospital
EMR) 2. Development of secondary database evidence network 3. Longitudinal data analysis, including patient journey and treatment pathway analytics |
ºÐ·ù |
±³¼ö |
¼º¸í |
°û¿µ¹ü |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Young-Beom Kwak / |
¼Ò¼Ó |
Á¦¾à°øÇаú |
Á÷À§ |
Á¶±³¼ö |
ÁÖ¿ä Çз |
ÇѾç´ëÇб³ ¾àÇдëÇÐ ¾àÇйڻç |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. Pharmaceutical & Clinical Analysis
2. Forensic Analysis (Doping Control) 3. Natural Product Analysis 4. Metabolomics 5. Molecular Networking based Mass Spectrometry 6. Absorption, Distribution, Metabolism, Excretion (ADME) 7. Pharmacokinetics 8. Drug-Drug Interaction |
ºÐ·ù |
±³¼ö |
¼º¸í |
Á¶°üÇü |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Kwan-Hyung Cho / |
¼Ò¼Ó |
¾àÇаú |
Á÷À§ |
±³¼ö |
ÁÖ¿ä Çз |
¼¿ï´ë ¾àÇдëÇÐ ÇÐ/¼®»ç
¿µ³²´ë ¾àÇдëÇÐ ¹Ú»ç |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. ³¿ë¼º¾à¹°°¡¿ëÈ(SNEDDS, °íüºÐ»êü)
2. Á¤Àü±âº¹ÇÕü °³¹ß 3. ½Å¾àÈĺ¸¹°Áú ¹°¸®ÈÇÐÀûƯ¼º±Ô¸í ¹× ÀÓ»óÁ¦Çü °³¹ß 4. »ó¿ëÈ Á¦Çüº¯°æ ¹× ½ÅÁ¦Çü °³¹ß 5. ¹°¼º ¹× Á¦Á¦È °ü·Ã ¸Ó½Å·¯´× ¸ðµ¨¸µ |
ºÐ·ù |
±³¼ö |
¼º¸í |
±è¿¬Á¤ |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Yeon-Jeong Kim / |
¼Ò¼Ó |
¾àÇаú |
Á÷À§ |
±³¼ö |
ÁÖ¿ä Çз |
¼¿ï´ëÇб³ ¾àÇм®»ç (2000.03 ~ 2004.02)
¼¿ï´ëÇб³ ¾àÇйڻç (2004.03 ~ 2010.02) |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. ¾Ï¸é¿ªÈ¯°æ Á¶Àý ¿¬±¸
2. ¹é½Å °³¹ß |
ºÐ·ù |
±³¼ö |
¼º¸í |
¹ÚÀ¯¹Ì |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
You-Mie Park / |
¼Ò¼Ó |
¾àÇаú |
Á÷À§ |
±³¼ö |
ÁÖ¿ä Çз |
¼¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇлç
¼¿ï´ëÇб³ ¾àÇдëÇÐ ¼®»ç University of Iowa Ph.D |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. õ¿¬¹°À» Ȱ¿ëÇÑ ±Ý¼Ó³ª³ëÀÔÀÚÀÇ ³ì»öÇÕ¼º ¹× ¾àÇÐÀû ÀÀ¿ë
|
ºÐ·ù |
±³¼ö |
¼º¸í |
¹Î°æ¾Æ |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Kyoung-Ah Min / |
¼Ò¼Ó |
¾àÇаú |
Á÷À§ |
ºÎ±³¼ö |
ÁÖ¿ä Çз |
¼¿ï´ëÇб³ ¾àÇлç (1997.03 ~ 2001.02)
¼¿ï´ëÇб³ ¾àÇм®»ç (2001.03 ~ 2003.02) ¹Ì±¹ Univ. of Michigan ¾àÇйڻç (2007.09 ~ 2013.05) |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. ¾à¹° ADME Æò°¡ ¹× ¾à¹°µ¿ÅÂÇÐ ºÐ¼®
2. ³ª³ëÀÔÀÚ ±â¹Ý ¾à¹°Àü´Þ½Ã½ºÅÛ °³¹ß ¹× »ý¹°¾àÁ¦ÇÐÀû Æò°¡ |
ºÐ·ù |
±³¼ö |
¼º¸í |
ÀÌÈñ¿µ |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
Hee-Young Lee / |
¼Ò¼Ó |
¾àÇаú |
Á÷À§ |
Á¶±³¼ö |
ÁÖ¿ä Çз |
ºÎ»ê´ëÇб³ ¾àÇлç
University of Florida Pharm.D Áß¾Ó´ëÇб³ ¾àÇйڻç |
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |
1. ÀÓ»ó½ÃÇè °³¹ß ¹× ¼öÇà
2. ÀÓ»ó,À¯Àüü µ¥ÀÌÅÍ ºÐ¼® ¹× ¿¹Ãø¸ðµ¨ °³¹ß 3. È®ÀåÇö½Ç ÀÓ»óÀû¿ë |
ºÐ·ù |
±³¼ö |
¼º¸í |
ÀÌÁ¦¿ø |
¼º¸í(¿µ¹®,ÇÑÀÚ) |
/ |
¼Ò¼Ó |
¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ |
Á÷À§ |
°´¿ø±³¼ö |
ÁÖ¿ä Çз |
|
ÁÖ¿ä ¿¬±¸ ºÐ¾ß |